Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review

[1] Stubblefield MD(2009)NCCN task force report: management of neuropathy in cancer J Natl Compr Canc Netw 7 S1-S26

[2] Burstein HJ(2009)Neurological adverse effects caused by cytotoxic and targeted therapies Nat Rev Clin Oncol 6 596-603

[3] Burton AW(2012)Chemotherapy-induced peripheral neurotoxicity (CIPN): an update Crit Rev Oncol Hematol 82 51-77

[4] Custodio CM(2008)Chemotherapy-induced neuropathy J Peripher Nerv Syst 13 27-46

[5] Deng GE(2002)Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity Eur J Cancer 38 1832-1837

[6] Schiff D(2011)First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study Ann Oncol 22 924-930

[7] Wen PY(1987)Phase I trial of taxol in patients with advanced cancer Cancer Treat Rep 71 1171-1177

[8] van den Bent MJ(2006)Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib J Clin Oncol 24 3113-3120

[9] Argyriou AA(2013)Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer J Oncol Pract 9 e234-240

[10] Bruna J(2013)Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry J Clin Oncol 31 2699-2707

[1] Stubblefield MD(2009)NCCN task force report: management of neuropathy in cancer J Natl Compr Canc Netw 7 S1-S26

[2] Burstein HJ(2009)Neurological adverse effects caused by cytotoxic and targeted therapies Nat Rev Clin Oncol 6 596-603

[3] Burton AW(2012)Chemotherapy-induced peripheral neurotoxicity (CIPN): an update Crit Rev Oncol Hematol 82 51-77

[4] Custodio CM(2008)Chemotherapy-induced neuropathy J Peripher Nerv Syst 13 27-46

[5] Deng GE(2002)Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity Eur J Cancer 38 1832-1837

[6] Schiff D(2011)First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study Ann Oncol 22 924-930

[7] Wen PY(1987)Phase I trial of taxol in patients with advanced cancer Cancer Treat Rep 71 1171-1177

[8] van den Bent MJ(2006)Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib J Clin Oncol 24 3113-3120

[9] Argyriou AA(2013)Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer J Oncol Pract 9 e234-240

[10] Bruna J(2013)Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry J Clin Oncol 31 2699-2707